FDA Approves Large-Scale Trial for Medicinal Ecstasy
It’s more than a love drug. The U.S. government yesterday commissioned Phase 3 trials for MDMA, a popular drug among clubgoers that floods the brain with warm feelings of love and trust. The research involves treating PTSD, a rampant problem among veterans and first responders, in cases that have not improved with traditional therapy. High risks of abuse — and a lot of skepticism — remain, but the trials, featuring at least 230 patients, are a huge step forward for the movement to legalize psychedelics for medical use.